Literature DB >> 8002257

Intrathecal narcotics in cancer pain--a case report.

H Frizelle1, V Hannon, M McNicholas.   

Abstract

A 61 year old female patient presented with metastatic bone pain three years post mastectomy. Standard oral analgesics and epidural morphine were ineffective in achieving pain control. Her pain was eventually controlled with morphine sulphate 48 mg daily via a self administered intrathecal pump. These devices are being used with increasing frequency and this case report highlights some of the problems encountered in this patient's management.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8002257     DOI: 10.1007/BF02943077

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  4 in total

1.  A validation study of the WHO method for cancer pain relief.

Authors:  V Ventafridda; M Tamburini; A Caraceni; F De Conno; F Naldi
Journal:  Cancer       Date:  1987-02-15       Impact factor: 6.860

2.  Hyperalgesia and myoclonus with intrathecal infusion of high-dose morphine.

Authors:  Franco de Conno; Augusto Caraceni; Cinzia Martini; Elio Spoldi; Monica Salvetti; Vittorio Ventafridda
Journal:  Pain       Date:  1991-12       Impact factor: 6.961

3.  High dose of spinal morphine produce a nonopiate receptor-mediated hyperesthesia: clinical and theoretic implications.

Authors:  T L Yaksh; G J Harty; B M Onofrio
Journal:  Anesthesiology       Date:  1986-05       Impact factor: 7.892

4.  Cancer pain relief using chronic morphine infusion. Early experience with a programmable implanted drug pump.

Authors:  R D Penn; J A Paice; W Gottschalk; A D Ivankovich
Journal:  J Neurosurg       Date:  1984-08       Impact factor: 5.115

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.